Progress and prospects of clinical cell therapy for liver cirrhosis and liver cancer
10.3760/cma.j.issn.1007-3418.2019.11.002
- VernacularTitle: 肝硬化与肝癌临床细胞治疗进展与展望
- Author:
Kai LIU
1
;
Lifeng WANG
2
;
Fusheng WANG
3
;
Ming SHI
3
Author Information
1. Peking University 302 Clinical Medical School, Beijing 100039, China;Treatment and Research Center for Infectious Diseases, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China
2. Treatment and Research Center for Infectious Diseases, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China;National Clinical Research Center for Infectious Diseases, Beijing 100039, China
3. Peking University 302 Clinical Medical School, Beijing 100039, China;Treatment and Research Center for Infectious Diseases, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China;National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Publication Type:Journal Article
- Keywords:
Liver cirrhosis;
Mesenchymal stem cells;
Liver cancer;
Cell therapy
- From:
Chinese Journal of Hepatology
2019;27(11):822-826
- CountryChina
- Language:Chinese
-
Abstract:
The treatment options for liver cancer and liver cirrhosis are limited. Cell therapy (immune cells, stem cells) can significantly improve the therapeutic effect by actively regulating body's immunity. In addition, when choosing different methods of cell therapy, clinicians should also fully consider the adverse reactions associated with cell therapy. This article reviews the progress of cells therapy in clinical trials of liver cancer and liver cirrhosis, including therapeutic mechanism, advantages, disadvantages and limitations.
